These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38130760)

  • 1. Phlpp1 Expression in Osteoblasts Plays a Modest Role in Bone Homeostasis.
    Karkache IY; Molstad DH; Vu E; Jensen ED; Bradley EW
    JBMR Plus; 2023 Dec; 7(12):e10806. PubMed ID: 38130760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid Lineage Ablation of
    Karkache IY; Damodaran JR; Molstad DHH; Mansky KC; Bradley EW
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phlpp1 is induced by estrogen in osteoclasts and its loss in Ctsk-expressing cells does not protect against ovariectomy-induced bone loss.
    Hanson MK; Karkache IY; Molstad DHH; Norton AA; Mansky KC; Bradley EW
    PLoS One; 2021; 16(6):e0251732. PubMed ID: 34143773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.
    Mattson AM; Begun DL; Molstad DHH; Meyer MA; Oursler MJ; Westendorf JJ; Bradley EW
    J Biol Chem; 2019 Aug; 294(31):11772-11784. PubMed ID: 31189651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Deletion of Menin in Mouse Mesenchymal Stem Cells: An Experimental and Computational Analysis.
    Abi-Rafeh J; Asgari M; Troka I; Canaff L; Moussa A; Pasini D; Goltzman D
    JBMR Plus; 2022 May; 6(5):e10622. PubMed ID: 35509630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.
    Tudpor K; van der Eerden BC; Jongwattanapisan P; Roelofs JJ; van Leeuwen JP; Bindels RJ; Hoenderop JG
    Bone; 2015 Mar; 72():14-22. PubMed ID: 25460576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP53 Regulates Bone Homeostasis by Controlling Rankl Expression in Osteoblasts and Bone Marrow Adipocytes.
    Hariri H; Kose O; Bezdjian A; Daniel SJ; St-Arnaud R
    J Bone Miner Res; 2023 Apr; 38(4):578-596. PubMed ID: 36726200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption.
    Cawley KM; Bustamante-Gomez NC; Guha AG; MacLeod RS; Xiong J; Gubrij I; Liu Y; Mulkey R; Palmieri M; Thostenson JD; Goellner JJ; O'Brien CA
    Cell Rep; 2020 Sep; 32(10):108052. PubMed ID: 32905775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The androgen receptor has no direct antiresorptive actions in mouse osteoclasts.
    Sinnesael M; Jardi F; Deboel L; Laurent MR; Dubois V; Zajac JD; Davey RA; Carmeliet G; Claessens F; Vanderschueren D
    Mol Cell Endocrinol; 2015 Aug; 411():198-206. PubMed ID: 25958043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts.
    Huang S; Eleniste PP; Wayakanon K; Mandela P; Eipper BA; Mains RE; Allen MR; Bruzzaniti A
    Bone; 2014 Mar; 60():235-45. PubMed ID: 24380811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of the Thyroid Hormone Transporter Mct8 in Osteoblast and Osteoclast Progenitors Increases Trabecular Bone in Male Mice.
    Lademann F; Tsourdi E; Rijntjes E; Köhrle J; Hofbauer LC; Heuer H; Rauner M
    Thyroid; 2020 Feb; 30(2):329-342. PubMed ID: 31910109
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteoclast differentiation by RANKL and OPG signaling pathways.
    Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E
    J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro.
    Sato T; Watanabe K; Masuhara M; Hada N; Hakeda Y
    J Bone Miner Metab; 2007; 25(1):19-27. PubMed ID: 17187190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
    Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone.
    Xiong J; Piemontese M; Onal M; Campbell J; Goellner JJ; Dusevich V; Bonewald L; Manolagas SC; O'Brien CA
    PLoS One; 2015; 10(9):e0138189. PubMed ID: 26393791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of bone cell function by RANKL and OPG in different in vitro models.
    Lin JM; Callon KE; Lin CQ; Bava U; Zheng MH; Reid IR; Cornish J
    Eur J Clin Invest; 2007 May; 37(5):407-15. PubMed ID: 17461987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.
    Takami M; Takahashi N; Udagawa N; Miyaura C; Suda K; Woo JT; Martin TJ; Nagai K; Suda T
    Endocrinology; 2000 Dec; 141(12):4711-9. PubMed ID: 11108286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
    Piemontese M; Xiong J; Fujiwara Y; Thostenson JD; O'Brien CA
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E587-93. PubMed ID: 27460899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.